- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Capecitabine,Trastuzumab, and Pertuzumab
Total 3099 results
-
Cancer Institute and Hospital, Chinese Academy...Chinese Academy of Medical Sciences Cancer Hospital,Shanxi Center; Chinese... and other collaboratorsNot yet recruitingBreast Cancer | Neoadjuvant TherapyChina
-
Hoffmann-La RocheCompletedBreast CancerChina, Korea, Republic of, Taiwan, Thailand
-
Fudan UniversityActive, not recruiting
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; ImmuniconCompletedColorectal CancerNetherlands
-
Chinese PLA General HospitalUnknown
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
The University of Hong Kong-Shenzhen HospitalTianjin Happy Life Technology Co., Ltd.Not yet recruitingFeasibility | Safety | Targeted Molecular Therapy | Effectiveness
-
Genentech, Inc.Hoffmann-La RocheRecruitingNeoplasm MetastasisAustralia, Korea, Republic of, China, United States, Portugal, Brazil, Singapore, Spain, United Kingdom, Belgium, Austria, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, France, Germany, Hong Kong, Hungary, Israel, Italy, Japan, Me... and more
-
Otto Metzger, MDGenentech, Inc.Active, not recruitingMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
The Methodist Hospital Research InstituteNovartis; Celgene CorporationCompletedBreast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Breast Adenocarcinoma | Inflammatory Breast CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingBreast Ductal Carcinoma In SituUnited States, Canada, Puerto Rico, Korea, Republic of
-
Hebei Medical University Fourth HospitalRecruitingAdvanced Breast Cancer | HER2-positive Breast CancerChina
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Seagen Inc.ParexelApproved for marketing
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
Nantes University HospitalUnknown
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Federation Francophone de Cancerologie DigestiveRecruiting
-
Fudan UniversityHoffmann-La RocheUnknown
-
Spanish Breast Cancer Research GroupCompleted
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
National Institute of Oncology, HungaryNot yet recruiting
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
The Greater Poland Cancer CentreActive, not recruiting
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
RemeGen Co., Ltd.Recruiting
-
Massachusetts General HospitalDana-Farber Cancer Institute; TakedaNot yet recruiting
-
Nantes University HospitalChugai Pharmaceutical; French Innovative Leukemia OrganisationCompleted
-
Seagen Inc.RecruitingGastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Carcinoma | Gallbladder Carcinoma | GEJ AdenocarcinomaUnited States, Japan
-
Orano Med LLCCompletedStomach Neoplasms | Breast Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms | Peritoneal NeoplasmsUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
University Medical Center GroningenCompleted
-
Hoffmann-La RocheActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, Germany, Korea, Republic of, Brazil, Poland, Russian Federation, Turkey, Spain, Australia, France, Canada, United Kingdom
-
University of Alabama at BirminghamJohns Hopkins University; Georgetown University; University of Chicago; University... and other collaboratorsActive, not recruitingMetastatic Breast Cancer | Leptomeningeal DiseaseUnited States
-
Hoffmann-La RocheCompleted
-
Jonsson Comprehensive Cancer CenterNovartis; Seagen Inc.RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsCompletedAcute Lymphoblastic Leukemia (ALL)United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
-
University of VirginiaRecruitingBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
BiogenCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La RocheRecruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedT-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsSarcoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
Hoffmann-La RocheCompletedColorectal CancerItaly, Korea, Republic of, United Kingdom, Belgium, Argentina, Denmark, Greece, Netherlands, Slovenia, Spain, Sweden, Turkey, Brazil, Bosnia and Herzegovina, France, Germany, Portugal, Egypt, Poland, Slovakia, Mexico, Serbia, Russian...